$8.71
0.06% today
Nasdaq, Apr 01, 06:20 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$8.71
-0.52 5.63% 1M
-2.90 24.98% 6M
-3.74 30.04% YTD
-3.23 27.05% 1Y
-2.17 19.94% 3Y
-6.20 41.58% 5Y
-50.64 85.32% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
+0.03 0.35%
ISIN
US92556V1061
Symbol
VTRS
Sector
Industry

Key metrics

Market capitalization $10.40b
Enterprise Value $23.88b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 12.08
EV/Sales (TTM) EV/Sales 1.63
P/S ratio (TTM) P/S ratio 0.71
P/B ratio (TTM) P/B ratio 0.56
Dividend yield 5.51%
Last dividend (FY24) $0.48
Revenue growth (TTM) Revenue growth -4.58%
Revenue (TTM) Revenue $14.68b
EBIT (operating result TTM) EBIT $1.05b
Free Cash Flow (TTM) Free Cash Flow $1.98b
Cash position $829.60m
EPS (TTM) EPS $-0.53
P/E forward 40.98
P/S forward 0.76
EV/Sales forward 1.73
Short interest 4.32%
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Viatris forecast:

4x Buy
40%
5x Hold
50%
1x Sell
10%

Analyst Opinions

10 Analysts have issued a Viatris forecast:

Buy
40%
Hold
50%
Sell
10%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
14,677 14,677
5% 5%
100%
- Direct Costs 8,825 8,825
0% 0%
60%
5,852 5,852
11% 11%
40%
- Selling and Administrative Expenses 1,101 1,101
16% 16%
8%
- Research and Development Expense 807 807
1% 1%
5%
3,944 3,944
18% 18%
27%
- Depreciation and Amortization 2,893 2,893
6% 6%
20%
EBIT (Operating Income) EBIT 1,051 1,051
49% 49%
7%
Net Profit -634 -634
1,259% 1,259%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
GlobeNewsWire
2 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Viatris To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
4 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Significant Losses In Viatris To Contact Him Directly To Discuss Their Options If you suffered significant losses in Viatris stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310).  [You ma...
Neutral
PRNewsWire
4 days ago
PITTSBURGH , March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m.
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 32,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today